Table 1. Clinical characteristics of PCa patients used for transcriptomics analysis.
| Characteristics | Total number | Percentage (%) | |
|---|---|---|---|
| Gleason score | 3 + 3 | 5 | 7.6 |
| 3 + 4 | 23 | 34.9 | |
| 3 + 5 | 1 | 1.5 | |
| 4 + 3 | 13 | 19.7 | |
| 4 + 4 | 10 | 15.2 | |
| 4 + 5 | 5 | 7.6 | |
| 5 + 4 | 7 | 10.6 | |
| 5 + 5 | 2 | 3.0 | |
| Pathological stage | T2cN0M0 | 36 | 54.6 |
| T2cN1M0 | 2 | 3.0 | |
| T3aN0M0 | 9 | 13.6 | |
| T3aN1M0 | 1 | 1.5 | |
| T3bN0M0 | 9 | 13.6 | |
| T3bN1M0 | 2 | 3.0 | |
| T4N0M0 | 5 | 7.6 | |
| NA | 2 | 3.0 | |
| Pathological progression | Localized | 36 | 54.6 |
| Locally advanced | 23 | 34.9 | |
| Metastatic | 6 | 9.1 | |
| NA | 1 | 1.5 | |
NA indicated that the information is missing.